Shanghai - Delayed Quote CNY
Sichuan Biokin Pharmaceutical Co.,Ltd. (688506.SS)
289.15
+4.15
+(1.46%)
At close: 3:00:03 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cash Flows from Used in Operating Activities Direct
4,058,670.13
4,058,670.13
-615,351.11
-258,649.09
-135,031.19
Operating Cash Flow
4,058,670.13
4,058,670.13
-615,351.11
-258,649.09
-135,031.19
Investing Cash Flow
-2,565,444.36
-2,565,444.36
-81,875.40
-34,546.14
156,147.46
Financing Cash Flow
1,273,890.36
1,273,890.36
90,842.99
1,139,411.07
88,655.24
End Cash Position
3,207,998.28
3,207,998.28
391,692.71
1,000,694.82
154,222.13
Capital Expenditure
-83,856.57
-83,856.57
-81,939.19
-34,556.41
-44,603.26
Issuance of Debt
1,903,930
1,903,930
447,700
375,000
242,000
Repayment of Debt
-518,960
-518,960
-239,740
-161,000
-181,000
Free Cash Flow
3,974,813.56
3,974,813.56
-697,290.30
-293,205.50
-179,634.45
12/31/2021 - 1/6/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade